UTERINE RHABDOMYOSARCOMA

• Autor(a) principal: Rivoire, Waldemar Augusto
• Data de Publicação: 2022
• Outros Autores: Monego, Heleusa Ione, Appel, Márcia, dos Reis, Ricardo, L. da Costa, Luiz Augusto, Capp, Edison
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Clinical and Biomedical Research
• Texto Completo: https://seer.ufrgs.br/index.php/hcpa/article/view/126144
• topic: Rabdomiossarcoma; sarcoma uterino; câncer; sangramento uterino; Rhabdomyosarcoma; uterine sarcoma; cancer; uterine bleeding

Uterine rhabdomyosarcomas are very rare. They are characterized by late diagnosis and poor prognosis. In this paper we report clinical manifestations of this tumor in a 37-year-old patient. Rhabdomyosarcomas are treated similarly to endometrial sarcomas. The initial therapy for most uterine sarcomas is exploratory laparotomy, total abdominal hysterectomy, and bilateral salpingo-oophorectomy. There is not much information about the epidemiologic risk factors for sarcoma; similarly, little work has been performed assessing molecular alterations in sarcomas. Because of their rarity, uterine sarcomas are not suitable for screening. They are best managed by specialists with expertise in these malignancies, but primary care physicians can play an important role in the early diagnosis. In suspected cases, endometrial biopsy or dilation and curettage may aid diagnosis.